PURPOSE Infl uenza and pneumococcal vaccination rates remain below national targets. We systematically reviewed the effectiveness of quality improvement interventions for increasing the rates of infl uenza and pneumococcal vaccinations among community-dwelling adults.
INTRODUCTION
I nfl uenza and pneumococcal disease are vaccine-preventable causes of morbidity and mortality. [1] [2] [3] Clinical practice guidelines have recommended routine infl uenza and pneumococcal vaccinations for elderly and nonelderly high-risk patients. [4] [5] [6] More recently, infl uenza vaccinations have been recommended for all individuals older than 6 months. 7 Even so, vaccination rates remain low. 8, 9 Studies of interventions for improving adult infl uenza and pneumococcal vaccination rates are numerous and have been synthesized in several systematic reviews. Jacobson and Szilagyi found that patient reminder and recall systems improved vaccination rates. 10 The US Preventive Services
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Task Force's (USPSTF) Community Guide to Preventive Services found supporting evidence for numerous interventions aimed at universally recommended vaccines 11 and for combinations of multiple interventions for vaccines targeted to high-risk groups. 12 , 13 Stone et al found that interventions involving organizational changes and teamwork were most effective for improving infl uenza or pneumococcal vaccination rates. 14 Most recently, Thomas et al found evidence of moderate quality that increasing community demand, vaccinating seniors during home visits, and deploying prevention facilitators working with health professionals improved infl uenza vaccination rates. 15 Though important, these reviews have a variety of limitations. For example, Thomas et al included randomized controlled trials, most of which were graded low in quality. Consequently, the authors were able to recommend only that practitioners implement home visits (2 studies) and practice prevention facilitators (4 studies), to improve vaccination rates. 15 The work of the USPSTF combined many vaccinations for different patient groups under targeted and universally recommended vaccinations. 11, 12 Stone et al, in their review of controlled clinical trials, examined the evidence more than a decade ago. We know of more than 50 additional studies that could be included, today. 14 Because previous reviews may be of limited currency and breadth, we undertook a systematic review and meta-analysis of randomized and nonrandomized studies of the effectiveness of quality improvement interventions for improving adult infl uenza and pneumococcal vaccination rates in the community. Our review is intended to provide a comprehensive quantitative summary of the results achieved by previous quality improvement studies.
METHODS

Study Selection and Data Extraction
We searched medical literature databases, including MEDLINE, EMBASE, Cochrane Library, Web of Science, and 5 other databases, as well as the reference lists of previous reviews up to August 2010, for relevant studies (Supplemental Appendix A, Exhibit A.2, available at http://annfammed.org/content/10/6/538/suppl/DC1). English language studies published in peer-reviewed journals were included if they involved elderly adults or adults with chronic diseases, involved a quality improvement intervention (see below), featured a parallel control group, and reported infl uenza or pneumococcal vaccination rates. We focused exclusively on the community setting to maximize relevance to primary care. Studies reporting suffi cient data to estimate log odds ratios (ORs) and standard errors were eligible for meta-analysis.
Two reviewers (D.L. and J.H.) selected studies and extracted data from each study in duplicate. Study quality was measured using the Downs and Black instrument, which assesses both randomized and nonrandomized studies on the same items. 16 Disagreements were resolved by consensus; remaining disagreements were resolved by the senior authors (J.A.J. and S.R.M.).
Data Synthesis
We synthesized results by performing random-effects meta-analyses of log odds ratios. We stratifi ed analyses by vaccination type and intervention category. To categorize the interventions, we modifi ed the taxonomy developed by Shojania et al used to classify quality improvement strategies (http://dx.doi.org/10.1001/ jama.296.4.427). 17, 18 Comparisons were included in meta-analyses if the control group was usual care; a control intervention aimed at nonvaccination behaviors or a different intervention for improving vaccination rates if the intervention was provided to both study arms. When study arms contributed to more than 1 comparison in a meta-analysis, the vaccination rate numerator and denominator were divided among the comparisons to avoid counting patients more than once. We accounted for unit of analysis errors by adjusting standard errors for literature-based values of intracluster correlations. 19, 20 Although we reported all pooled odds ratios, we interpreted only those odds ratios comprised of 3 or more comparisons. Heterogeneity was characterized with I 2 statistics. We explored heterogeneity by substratifying interventions with clear grounds for delineating strata and suffi cient studies to divide into strata of 3 or more comparisons. Clinician reminders were stratifi ed according to whether the reminder system was immunization specifi c or targeted a range of preventive care behaviors, and whether reminders were generated from patients' medical histories. Patient outreach interventions were stratifi ed by communication medium. Finally, team change interventions were stratifi ed by type of personnel involved and whether they administered vaccine independently.
The effects of Downs and Black scores and randomization on pooled odds ratios were examined by meta-regression. Finally, we tested for publication bias by visual inspection of funnel plots and by using Harbord's test. 21 Harbord's test is an alternative to Egger's test that mitigates false positives in meta-analyses of odds ratios. Analyses were performed using Stata 11 (StataCorp LP).
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RESULTS
Overview of Studies
We included 106 and excluded 208 citations ( Figure  1 ). Citations were most commonly excluded because IMPROV ING VACCINAT ION R AT ES they lacked a concurrent control group (n = 112, 54%) or took place in hospital or in a nursing home (n = 27, 13%) (Supplemental Appendix A, Exhibit A.3 and A.4). Interreviewer reliability for inclusion of electronic search citations was substantial (91% agreement, κ = 0.8). The included studies featured 470,175 patients (Table  1 and Supplemental Appendix A, Exhibit A.5). Studies took place primarily in the United States (82 studies), Canada (9 studies), and the United Kingdom (6 studies). A range of settings was represented, including academic primary care practices (41 studies), community practices (21 studies), managed care organizations (13 studies), Medicare-affi liated organizations (11 studies), and Veterans Affairs medical centers (8 studies) . A few studies intervened at nonclinical sites, such as senior centers or workplaces. Most studies targeted the elderly for vaccination, either alone (54 studies), or in combination with high-risk nonelderly patients (27 studies).
Quality of Included Studies
Seventy-seven studies provided suffi cient data for meta-analyses of odds ratios (Table 1 and Supplemental Appendix A, Exhibit A.6). Fifty-six studies (75%) were randomized or quasi-randomized controlled trials. The remaining studies were controlled before-and-after (7 studies) and observational (12 studies) designs. The median Downs and Black scores ranged from 14 to 26, with a median score of 21 points (the median Downs and Black scores ranged from 14 to 26, with a median score of 21 points (total possible score = 32, with greater scores indicating higher methodologic quality).
We examined individual items of the Downs and Black instrument (Supplemental Appendix B, http:// annfammed.org/content/10/6/538/suppl/DC1). The most important weaknesses were unit-ofanalyses errors and insuffi cient reporting and adjustment for potential confounders. We corrected for unit-of-analysis errors in 38 (51%) of studies. Potential confounders included previous vaccination status, health status, and demographic characteristics. The proportion of studies reporting and accounting for these confounders, whether by showing that randomization achieved a balanced distribution of covariates or by statistical adjustment, was 60%. Additional methodological weaknesses were lack of blinding of study subjects or assessors to intervention allocation and contamination, in which the intervention may have affected the treatment of nonintervention patients at the same site. Contamination is prevented by allocation at the physician, practice, or region level, which occurred in only 31 studies (40%).
Main Meta-Analyses
There were 111 comparisons from 77 studies that contributed to the overall meta-analysis ( Table 1) . The pooled odds ratio expressing the effectiveness of all quality improvement interventions for either vaccination was 1.61 (95% CI, 1.49-1.75; P <.001; I 2 = 85%). 23, 24 appeared to be more effective than those providing a small reward in addition to preexisting third-party vaccination coverage. 25, 26 Insuffi cient studies were available to test this hypothesis statistically, however. Audit and feedback fi ndings were driven largely by results from the single study by Buffi ngton et al, who were able to improve vaccination rates with regularly updated posters in physician offi ces tracking vaccination progress. 27 Clinician reminders (OR = 1.53, 95% CI, 1. 28 and clinics in public housing buildings. 29 These interventions were effective overall, but what elements of these were effective and where are diffi cult to discern, because a wide variety of intervention sites were implemented in a small number of studies. Case management and clinician education were ineffective. Note: Forest plot showing pooled odds ratios from random effects meta-analyses. Vaccination rates provided are crude estimates generated by summing patients among studies. Many studies contributing odds ratios for meta-analysis did not provide crude counts.
Infl uenza Vaccination
Pneumococcal Vaccinations
a Pooled odds ratios from fewer than 3 comparisons are reported but considered insuffi cient for interpretation. 
Meta-Analyses Within Intervention Substrata
Interventions featuring clinician reminders, team change, and patient outreach had moderate to high heterogeneity and suffi cient comparisons for substratifi cation. For clinician reminders, most heterogeneity was explained by declining odds ratios with time. For patient outreach and team change, the results of metaanalyses within intervention substrata are presented in Table 2 (forest plots are available in Supplemental Appendix C, at http://annfammed.org/content/10/6/538/suppl/DC1). Several fi ndings require qualifi cation. Among patient outreach strategies for infl uenza, community media campaigns appeared most effective. This fi nding should be interpreted cautiously, however, because studies took place in settings with relatively captive audiences and a high prevalence of high-risk patients (eg, seniors' centers). 29, 30 For pneumococcal vaccination, the pooled odds ratio for waiting and examination room posters may also be misleadingly high, because there were few comparisons (n = 5), and the highest performing comparisons combined posters with other effective interventions. 31, 32 In 2 studies that considered them alone, waiting and examination room posters were not signifi cantly associated with vaccination rates. 31, 32 Generally, outreach methods involving personal contact with patients achieved higher pooled odds ratios. For infl uenza vaccinations, the most effective intervention, excepting community media campaigns, was telephone reminders delivered by clinic staff. For pneumococcal vaccinations, offi ce brochures handed out to eligible patients by clinic staff before their appointments was most effective. Meta-regression detected signifi cant differences between pneumococcal vaccination outreach strategies. Offi ce brochures at the point of care were 3.87 times more effective than mailed reminders, whereas community media campaigns, patient-held preventive care checklists, and waiting or examination room posters were, respectively, 0.85, 0.77, and 0.75 times less effective than mailed reminders. Among team change interventions Note: Forest plot showing pooled odds ratios from random effects meta-analyses. Vaccination rates provided are crude estimates generated by summing patients among studies. Many studies contributing odds ratios for meta-analysis did not provide crude counts.
a Pooled odds ratios from fewer than 3 comparisons are reported, but considered insuffi cient for interpretation. No comparisons involving patient fi nancial incentives were available for meta-analysis. a a a a a a a a a a a 1 1 0
Intervention OR (95% CI) Comparisons
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for infl uenza vaccinations, we found that having nurses assume responsibility for administering vaccinations was effective, whereas interventions in which nurses or pharmacists assessed patients and reminded physicians, but did not themselves administer vaccinations, were ineffective. We were unable to examine this relationship in studies of pneumococcal vaccinations because of insuffi cient comparisons.
Numbers Needed to Treat
Results for effective quality improvement strategies are summarized as numbers needed to treat (NNT), assuming baseline levels of vaccination similar to those reported in community studies of elderly adults 8 (Table  3 and Supplemental Appendix C, Exhibit C.5).
Sensitivity Analyses and Publication Bias
Randomized study design was not signifi cantly associated with study odds ratios within intervention strata. After excluding 2 clear outlier studies, 33, 34 quality score was also not signifi cantly associated with study odds ratios for any intervention. Funnel plots showed higher odds ratios in smaller studies. Harbord's test was positive for small study effects among studies of patient outreach for infl uenza and pneumococcal vaccinations and of team change for infl uenza vaccinations. These fi ndings suggest potential publication bias.
DISCUSSION
We reviewed the evidence for effectiveness of quality improvement interventions for increasing infl uenza and pneumococcal vaccination rates. Most interventions were associated with modest improvements in vaccination rates.
Team change, patient outreach, and clinician reminders were effective for both infl uenza and pneumococcal vaccinations. We found that interventions involving team change were effective, especially where nurses had been assigned responsibilities for administering vaccine. Confi guring additional personnel so that they are able relieve physicians of vaccinations Note: See forest plots in Supplemental Appendix C for more detail.
a Pooled odds ratios signifi cant at P <.05.
b No. <3. Although we avoided interpreting pooled odds ratios from fewer than 3 studies, they are presented here for completeness.
seems important to successful team change.
14 Additionally, patient outreach may better increase vaccinations to the extent that direct personal contact is achieved. A previous review has similarly reported that reminders involving person-to-person telephone contact were most effective. 10 Clinician reminders and education were associated with greater improvements for pneumococcal than for infl uenza vaccinations. Awareness and support may be less common for pneumococcal 35 than for infl uenza vaccinations, [36] [37] [38] making pneumococcal vaccinations relatively low hanging fruit. Audit and feedback appeared effective for infl uenza, but not pneumococcal, vaccinations. Audit and feedback may have been effective for infl uenza vaccinations because of the prominent tracking posters used in Buffi ngton et al. 27 The use of materials with high visual appeal and clarity has been previously associated with increased vaccination rates.
14 Clinician and patient fi nancial incentives were both effective for infl uenza vaccinations, but they could not be evaluated for pneumococcal vaccinations. The 2 successful studies of patient fi nancial incentives took place in out-of-pocket payment environments. 23, 24 Where demand for vaccinations is not pent up by inability to pay, the benefi t of patient incentives may be smaller. 25, 26 Case management, surprisingly, was not very effective-possibly because case managers may have prioritized other disease-related process of care.
Several limitations of our review should be borne in mind. Our funnel plots and associated tests suggested publication bias, which may have led our pooled odds ratios to be overly optimistic. Our review also did not address the economic value of the interventions. Additionally, the included studies may not generalize well to nonelderly adults or adults not in a physician's care, for whom vaccination recommendations have recently been expanded. 7 More importantly, we have taken a highly inclusive approach toward meta-analysis. There are 2 major limitations of this approach. First, our analysis of Downs and Black items identifi ed a high prevalence of design or reporting fl aws in the included studies. Lack of blinding may be relatively unimportant for quality improvement interventions designed to act, in part, by increasing awareness of vaccinations and for outcomes that can be measured relatively objectively by reviewing charts or billing data. Only 60% of studies reported and accounted adequately for potential confounders, however. This proportion was higher in randomized than in observational studies.
We have nonetheless reported odds ratios pooled from all studies. Neither randomization nor Downs and Black scores were associated with signifi cant differences in odds ratios. The inclusion of a wide range of studies allowed us to produce quantitative summaries for many intervention categories. In particular, interventions requiring policy support or action on a community scale, such as audit and feedback and community media campaigns, are diffi cult to randomizeobservational studies comprise an important source of insight. 39 Our study quality tables (Supplemental Appendix B) provide further detail on methodological issues for potential users.
Second, many of our pooled estimates contained residual heterogeneity. Our ability to explore heterogeneity was limited by lack of evidence. 40 For example, reasons for decreases in the effectiveness of clinician reminders in recent years are unknown. We have incorporated heterogeneity into our meta-analysis by using a random-effects approach. Users should interpret pooled odds ratios as estimates of the average Patient outreach (mailed print materials) 9
Case management 11
Patient outreach (community media) 13
Patient outreach (preventive care checklists) 17 NNT = number needed to treat.
Note: Interventions included in this table had summary odds ratios statistically greater than 1.0 (P <.05) based on 3 or more studies. Numbers needed to treat are provided assuming other baseline vaccination rates in Supplemental Appendix C, Exhibit C.5.
intervention effect, as opposed to a single, true effect. Our 95% confi dence limits may provide bounds on the expected performance of the intervention under most circumstances. In any event, a single true effect would not likely be useful, because most users can identify mitigating or potentiating factors unique to their circumstances. Our estimates provide a preliminary basis for selecting interventions; potential users should examine our summaries of individual studies (Supplemental Appendix A. Exhibit A.5) and intervention-specifi c forest plots (Supplemental Appendix B) in light of their own circumstances and a theoretical understanding of behavior change. 41, 42 Building on previous reviews, we have produced a comprehensive, quantitative summary of the effectiveness of interventions to improve infl uenza and pneumococcal vaccination rates. Our results suggest that (1) shifting vaccine administration from physicians to members of the primary care team with clear responsibilities for chronic and preventive care and (2) activating patients through personal outreach may stand the best chance of improving vaccination rates in community dwelling adults. Nonetheless, practitioners and policy makers should temper their expectations of quality improvement interventions. In few treatment arms had vaccination rates improved suffi ciently to meet national policy targets. 43, 44 Further research is required to develop and evaluate more potent approaches and to better understand how and why they work.
